Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KREBS BIOCHEMICALS vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KREBS BIOCHEMICALS SUVEN PHARMACEUTICALS KREBS BIOCHEMICALS/
SUVEN PHARMACEUTICALS
 
P/E (TTM) x -8.2 135.7 - View Chart
P/BV x - 16.1 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KREBS BIOCHEMICALS   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    KREBS BIOCHEMICALS
Mar-24
SUVEN PHARMACEUTICALS
Mar-24
KREBS BIOCHEMICALS/
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs93767 12.2%   
Low Rs57375 15.1%   
Sales per share (Unadj.) Rs23.441.3 56.6%  
Earnings per share (Unadj.) Rs-9.211.8 -77.6%  
Cash flow per share (Unadj.) Rs-6.013.9 -43.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-55.380.5 -68.7%  
Shares outstanding (eoy) m21.56254.57 8.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.213.8 23.1%   
Avg P/E ratio x-8.248.4 -16.9%  
P/CF ratio (eoy) x-12.541.0 -30.4%  
Price / Book Value ratio x-1.47.1 -19.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,614145,357 1.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1621,359 11.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m50410,514 4.8%  
Other income Rs m5619 0.7%   
Total revenues Rs m50911,133 4.6%   
Gross profit Rs m-874,058 -2.1%  
Depreciation Rs m68546 12.4%   
Interest Rs m4775 62.9%   
Profit before tax Rs m-1974,057 -4.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m01,054 0.0%   
Profit after tax Rs m-1973,003 -6.6%  
Gross profit margin %-17.338.6 -44.8%  
Effective tax rate %026.0 -0.0%   
Net profit margin %-39.128.6 -137.0%  
BALANCE SHEET DATA
Current assets Rs m17413,623 1.3%   
Current liabilities Rs m6182,061 30.0%   
Net working cap to sales %-88.0110.0 -80.1%  
Current ratio x0.36.6 4.3%  
Inventory Days Days64318 20.0%  
Debtors Days Days138464 29.7%  
Net fixed assets Rs m1,6079,909 16.2%   
Share capital Rs m216255 84.7%   
"Free" reserves Rs m-1,40820,232 -7.0%   
Net worth Rs m-1,19220,487 -5.8%   
Long term debt Rs m1,8350-   
Total assets Rs m1,78223,532 7.6%  
Interest coverage x-3.255.4 -5.8%   
Debt to equity ratio x-1.50-  
Sales to assets ratio x0.30.4 63.3%   
Return on assets %-8.413.1 -64.5%  
Return on equity %16.514.7 112.9%  
Return on capital %-23.420.2 -116.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m010,857 0.0%   
Fx outflow Rs m62,119 0.3%   
Net fx Rs m-68,737 -0.1%   
CASH FLOW
From Operations Rs m233,585 0.6%  
From Investments Rs m-78-3,623 2.2%  
From Financial Activity Rs m56-138 -40.3%  
Net Cashflow Rs m1-176 -0.3%  

Share Holding

Indian Promoters % 72.7 0.0 -  
Foreign collaborators % 0.0 50.1 -  
Indian inst/Mut Fund % 0.5 27.7 1.8%  
FIIs % 0.5 10.7 4.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 27.3 49.9 54.6%  
Shareholders   9,425 69,337 13.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KREBS BIOCHEMICALS With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on KREBS BIOCHEMICALS vs SUVEN PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KREBS BIOCHEMICALS vs SUVEN PHARMACEUTICALS Share Price Performance

Period KREBS BIOCHEMICALS SUVEN PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day 0.13% 1.41% 1.23%
1-Month -0.23% 3.37% -0.24%
1-Year 2.24% 111.75% 43.62%
3-Year CAGR -18.90% 37.70% 20.35%
5-Year CAGR -1.23% 50.43% 26.24%

* Compound Annual Growth Rate

Here are more details on the KREBS BIOCHEMICALS share price and the SUVEN PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of KREBS BIOCHEMICALS hold a 72.7% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 50.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KREBS BIOCHEMICALS and the shareholding pattern of SUVEN PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, KREBS BIOCHEMICALS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

SUVEN PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of KREBS BIOCHEMICALS, and the dividend history of SUVEN PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.